Skip to main content
. Author manuscript; available in PMC: 2025 Jan 4.
Published in final edited form as: Risk Anal. 2013 Mar 22;33(4):703–749. doi: 10.1111/risa.12044

Table XIV.

Comparison of Modeled and Observed Secondary OPV Infections Following NIDs in Cuba, Based on Cumulative Force of Infection and Percentage Seropositive Before the Next NID, Respectively

Percentage secondarily infected (95% CI, if reported)
Source Type 1 Type 2 Type 3

Más Lago et al.(48)
 - Children born during first month after 1991 NID (n = 28) 46.4% (27.6–65.2) 46.4% (27.6–65.2) 17.9% (3.4–32.4)
 - Children born during second month after 1991 NID (n = 37) 5.4% (0.0–12.8) 13.5% (2.3–24.7) 8.1% (0.0–17.1)
 - Children born during third month after 1991 NID (n = 53) 0.0% (0.0–0.0) 1.9%a (0.0–5.7) 0.0% (0.0–0.0)
Más Lago et al.(95)
 - Children born during first or second month after 1997 NID (n = 14) 0.0% 0.0% 0.0%
Model
 - Fully susceptible children exposed from day 1 after 1991 NID 14.0% 16.3% 8.4%
 - Fully susceptible children exposed from day 16 after 1991 NID 5.5% 5.3% 3.2%
 - Fully susceptible exposed from day 31 after 1991 NID 1.9% 1.6% 1.1%
 - Fully susceptible exposed from day 46 after 1991 NID < 1% < 1% < 1%

Acronyms: CI = confidence interval; NID = national immunization day; OPV = oral poliovirus vaccine

a

Seropositivity in this age group may reflect residual maternal immunity given that maternal antibody levels were still at 24.5% in 1-month younger children at the time of serologic testing.(48)